Search
  • Search


Denmark: Tenders/Statens Serum Institut/Advance purchase agreement for the reservation and supply of pandemic influenza vaccine
  1. Competition notice published

    Jun 4, 2024 1:43 PMJune 4, 2024 1:43 PM
  2. Change in competition

    Jun 14, 2024 7:18 AMJune 14, 2024 7:18 AM
  3. Contract signed

    Oct 16, 2024 12:00 AMOctober 16, 2024 12:00 AM
  4. Result notice published

    Nov 14, 2024 3:32 PMNovember 14, 2024 3:32 PM

Brief

Advance purchase agreement for the reservation and supply of pandemic influenza vaccine

Awarded

The competition has ended and a winner has been selected.

Qualification deadline
Nov 13, 2024Expired
Award
Delivery 20% and 2 more
Procedure
With negotiationTwo stages
Agreement
Buying goodsover 2 years

Brief

The purpose of this tender is to ensure fast delivery of pandemic influenza vaccines in the event of an influenza pandemic during the contract period. The contract (advance purchase agreement) regards reservation of the supplier’s production capacity and the contract will contain an option for purchase of pandemic influenza vaccine in the event of an influenza pandemic called by the WHO during the contract period. The reserved volume of pandemic vaccine is expected to be 7.6 million doses; however, the number of doses may be reduced by SSI as described in the tender documents. SSI expects that the Agreement cannot be awarded without prior negotiations with potential suppliers due to the specific circumstances related to the nature and the complexity of the Agreement and the legal and financial aspects and the associated risks. In essence, the procedure encompasses a complex advance purchase agreement, and SSI is dependent on further information from potential suppliers in order to establish a complete and adequate set of terms and conditions in accordance with what the market operators are able to meet. This makes it necessary for SSI to be able to negotiate various as-pects of both the tender documents and the tenders received and potentially make various changes to the tender documents. Hence, the procurement will be conducted as a negotiated procedure pursuant to the Danish Procurement Act (udbudsloven). All terms and requirements that are not minimum requirements may be subject to negotiation and may be changed or withdrawn during the tender procedure according to SSI’s decision. Thus, SSI encourages all economic operators who comply with the minimum requirements (stated in the Tender Specification, paragraph 5) to apply for prequalification, even if the economic operator cannot comply with other terms and requirements.

Farmasøytisk engroshandel

Result

TED
  • SEQIRUS UK LIMITED
    Winner
  • Number of tenders received
    1
  • Contract value
    DKK 1

Custom Assessment Criteria

  • Get answers to your bid/no-bid criteria

    Set them up once and Cobrief answers them in every tender

Will you bid?

The agent sets up the bid and writes the first draft. Free for 14 days.

Award Criteria

  • Description

    Reference is made to the Tender Specifications, Appendix A, section 1.1.

    Source

    No source found in the documents. Check the weight against the tender documents.

  • Description

    Reference is made to the Tender Specifications, Appendix A, section 1.2.

    Source

    No source found in the documents. Check the weight against the tender documents.

  • Description

    Reference is made to the Tender Specifications, Appendix A, section 1.3.

    Source

    No source found in the documents. Check the weight against the tender documents.

  • Description

    Reference is made to the Tender Specifications, Appendix A, section 1.4.

    Source

    No source found in the documents. Check the weight against the tender documents.

Previous winners

  • Who are you up against?

    The suppliers who have won similar contracts at Statens Serum Institut

From the notice

  • The purpose of this tender is to ensure fast delivery of pandemic influenza vaccines in the event of an influenza pandemic during the contract period. The contract (advance purchase agreement) regards reservation of the supplier’s production capacity and the contract will contain an option for purchase of pandemic influenza vaccine in the event of an influenza pandemic called by the WHO during the contract period. The reserved volume of pandemic vaccine is expected to be 7.6 million doses; however, the number of doses may be reduced by SSI as described in the tender documents. SSI expects that the Agreement cannot be awarded without prior negotiations with potential suppliers due to the specific circumstances related to the nature and the complexity of the Agreement and the legal and financial aspects and the associated risks. In essence, the procedure encompasses a complex advance purchase agreement, and SSI is dependent on further information from potential suppliers in order to establish a complete and adequate set of terms and conditions in accordance with what the market operators are able to meet. This makes it necessary for SSI to be able to negotiate various as-pects of both the tender documents and the tenders received and potentially make various changes to the tender documents. Hence, the procurement will be conducted as a negotiated procedure pursuant to the Danish Procurement Act (udbudsloven). All terms and requirements that are not minimum requirements may be subject to negotiation and may be changed or withdrawn during the tender procedure according to SSI’s decision. Thus, SSI encourages all economic operators who comply with the minimum requirements (stated in the Tender Specification, paragraph 5) to apply for prequalification, even if the economic operator cannot comply with other terms and requirements.Main features of the procedureAfter receipt of Indicative Offers (INDO1), SSI will conduct individual negotiation meetings with all tenderers who have submitted an INDO within the deadline stated. The negotiations will be conducted in accordance with the principle of equal treatment, and all tenderers will be given the same amount of time for negotiations with SSI. After the negotiations, SSI may choose to issue revised tender documents for further Indicative Offers or Best and Final Offer (BAFO). The tenderers will be informed thereof at the same time with an invitation to submit an INDO or BAFO. SSI will not pay a participation fee to the tenderers. For further information on the process of the negotiations, reference is made to the tender specifications, paragraph 11.

  • Contact

    nea@ssi.dk
  • Type
    Result · Prequalification
  • Location
    Byen København
  • Main code
    Vaccines
    33651600

Similar active competitions

  • Nemzeti Népegészségügyi és Gyógyszerészeti Központ

    Farmasøytisk engroshandel

    „Konjugált pneumococcus elleni vakcina”

    A Nemzeti Népegészségügyi és Gyógyszerészeti Központ 32 hónapra, Budapestre keres 13-nál több szerotípust tartalmazó konjugált pneumococcus elleni vakcinát 80 000 kisgyermek oltásához. A szállítandó mennyiség a választott oltási rendtől függően 400 000 adag, további 40 000 adag opcióval, vagy 533 340 adag, további 53 334 adag opcióval; mindkét esetben az alap- és opciós mennyiségen felül legalább 20%-os árurabattot kell biztosítani. Az értékelésben az egy gyermek oltásához szükséges vakcina nettó ára 80 pontot, a 15 meghatározott szerotípus lefedettsége 15 pontot, a további szerotípusok lefedettsége pedig 5 pontot ér. Alkalmassági igazolásként az előző 3 évből összesen legalább 12 500 adag emberi alkalmazású oltóanyag szerződésszerű szállítására vonatkozó referenciát kell bemutatni.

    Competition
    Dec 1, 2026(12 days)
  • Sykehusinnkjøp Hf

    Farmasøytisk engroshandel

    2661a RHF sesonginfluensavaksine

    Sykehusinnkjøp HF trenger sesonginfluensavaksine til helsepersonell/ansatte på sykehusene i de fire regionale helseforetakene (Helse Sør-Øst RHF, Helse Vest RHF, Helse Midt-Norge RHF og Helse Nord RHF) gjennom en rammeavtale med en maksimal totalverdi på 38 millioner kroner.

    Framework agreement
    Nov 23, 2026(4 days)
    NOK 38,000,000
  • Adda Inköpscentral AB

    Farmasøytisk engroshandel

    Vaccin mot covid-19 DIS

    Adda Inköpscentral AB behöver vaccin mot covid-19 genom ett dynamiskt inköpssystem med en maximal total avtalsperiod på 10 år och ett uppskattat totalt kontraktsvärde på 3 miljoner SEK.

    Dynamic purchasing system
    Sep 30, 2035(100+ days)
    SEK 3,000,000